Lactulose for Constipation
Lactulose is an effective osmotic laxative for chronic constipation, demonstrating significant efficacy with a large increase in global relief compared to placebo (RR 2.42), though it may be less effective than polyethylene glycol (PEG) for this indication. 1
Mechanism and Efficacy
Lactulose works as an osmotic laxative in the colon to promote peristalsis. Its efficacy for constipation is well-established:
- Produces significant improvement in constipation symptoms compared to placebo
- Associated with 267 more responders per 1,000 compared to placebo 1
- Has minimal systemic absorption, reducing risk of systemic side effects 1
However, comparative studies suggest PEG may be more effective:
- PEG shows better outcomes in stool frequency per week, stool form, and relief of abdominal pain compared to lactulose 2
- This superior efficacy has been demonstrated in both adults and children 2
Dosing Recommendations
For chronic constipation in adults:
- Initial dose: 10-20g (15-30mL or 1-2 packets) daily 1
- May increase to 40g (60mL or 2-4 packets) daily if needed 1
- Can be administered as a single daily dose (preferably at night) or divided into two doses 1
FDA-approved dosing:
- 2-3 tablespoonfuls (30-45mL, containing 20-30g) three or four times daily 3
- Dose may be adjusted every 1-2 days to produce 2-3 soft stools daily 3
Special Populations
Lactulose offers advantages for specific patient groups:
- Safe in elderly patients 1
- Safe for patients with diabetes (minimal effect on blood sugar in non-insulin dependent type 2 diabetes) 1
- Preferred osmotic agent in pregnancy 1
- No dose adjustment required for renal impairment 1
For pediatric patients:
- Initial daily oral dose in infants: 2.5-10mL in divided doses 3
- For older children and adolescents: 40-90mL total daily dose 3
- Dose should be reduced immediately if diarrhea occurs 3
Side Effects and Monitoring
Common side effects include:
Monitoring recommendations:
- Evaluate response after 4 weeks of treatment 1
- Assess for side effects and adjust dosing as needed 1
- Periodic evaluation every 4-6 weeks for continued treatment 1
- Ensure adequate hydration during treatment 1
Patient Preference Considerations
Research on patient preferences shows:
- Powder formulation may be preferred over liquid lactulose by many patients 4
- 77% more patients preferred powder over liquid lactulose in one study 4
- Better palatability may improve compliance 5
Alternative Options
Consider these alternatives when lactulose is insufficient:
- Polyethylene glycol (PEG) may be more effective for chronic constipation 2
- A senna-fiber combination has shown better efficacy than lactulose in elderly patients with chronic constipation, with higher stool frequency and better consistency 6
- Lactitol has shown comparable efficacy to lactulose with potentially fewer adverse events (31.2% vs 62.1%) 5